Trajectory Landscapes for Therapeutic Strategy Design in Agent-Based Tumor Microenvironment Models

Eric Cramer, Laura M. Heiser, and Young Hwan Chang · 2026

Read Trajectory Landscapes for Therapeutic Strategy Design in Agent-Based Tumor Microenvironment Models by Eric Cramer, Laura M. Heiser, and Young Hwan Chang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2603-18333.txt.

Introduction

Cramer, Heiser, and Chang build trajectory landscapes for therapy design in agent-based tumor models. Multiplex imaging gives rich spatial data but few time points per patient. They perturb a tumor microenvironment model to build trajectory ensembles and a low-dimensional landscape. A Markov state model captures metastable states and transitions from spatial summary series. Patient snapshots map onto the landscape, and a decision process form supports treatment scheduling.

Catalog record

CREATOREric Cramer, Laura M. Heiser, and Young Hwan Chang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31395
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2603.18333

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Trajectory Landscapes for Therapeutic Strategy Design in Agent-Based Tumor Microenvironment Models Eric Cramer, Laura M. Heiser, and Young Hwan Chang Abstract Multiplex tissue imaging (MTI) enables high-dimensional, spatially resolved measurements of the tumor microenvironment (TME), but most clinical datasets are temporally undersampled and longitudinally limited, restricting direct inference of underlying spatiotemporal dynamics and effective intervention timing. Agent-based models (ABMs) provide mechanistic, stochastic simulators of TME evolution; yet their high-dimensional state space and uncertain parameterization make direct control design challenging. This work presents a reduced-order, simulation-driven framework for therapeutic strategy design using ABM-derived trajectory ensembles. Starting from a nominal ABM, we systematically perturb biologically plausible parameters to generate a set of simulated trajectories and construct a low-dimensional trajectory landscape describing TME evolution. From time series of spatial summary statistics extracted from the simulations, we learn a probabilistic Markov State Model (MSM) that captures metastable states and the transitions between them. To connect simulation dynamics with clinical observations, we map patient MTI snapshots onto the landscape and assess concordance with observed spatial phenotypes and clinical outcomes. We further show that conditioning the MSM on dominant governing parameters yields group-specific transition models to formulate a finite-horizon Markov Decision Process (MDP) for treatment scheduling. The resulting framework enables simulation-grounded therapeutic policy design for partially observed biological systems without requiring longitudinal patient measurements. I INTRODUCTION The application of feedback and decision-making frameworks to biological systems has the potential to move oncology from fixed, open-loop treatment schedules toward adaptive, state-aware therapeutic strategies [ 1 , 2 ] . In cancer, the tumor microenvironment (TME) evolves as a complex, spatially distributed stochastic dynamical system [ 3 ] , where tumor growth, immune infiltration, and stromal remodeling drive trajectories toward either immune control or immune-escape [ 4 ] . Designing such strategies is challenging due to limited observability. Although multiplex tissue imaging (MTI) provides high-dimensional, spatially resolved measurements of the TME [ 5 ] , clinical samples are sparse and provide irregular snapshots of an evolving process. As a result, most patient datasets are insufficient to infer the underlying spatiotemporal dynamics, identify transitions between latent dynamical states of the TME, or determine when therapeutic intervention is most effective. Designing intervention strategies therefore requires models that relate therapeutic inputs to measurable physiological state. Ordinary differential equation (ODE) models remain widely used due to their analytical tractability, but their well-mixed assumption fails to capture the spatial heterogeneity revealed by MTI [ 6 ] . Models that track only global population averages cannot represent spatially organized mechanisms critical to therapy response—such as T cell exclusion, compartment segregation, and localized exhaustion gradients. These limitations motivate approaches that explicitly capture spatiotemporal TME dynamics while enabling reduced-order abstractions suitable for decision-making. Agent-based models (ABMs) provide a mechanistic framework for representing stochastic, spatially resolved cell–cell and cell–matrix interactions in the TME [ 7 , 8 ] . However, calibrating ABMs to clinical data remains difficult because temporally undersampled measurements of the TME provide only partial observations of the underlying dynamical state. Consequently, identifying a single optimal set of model parameters is often underdetermined and may fail to capture the range of dynamical behaviors relevant for therapeutic strategy design [ 9 , 10 ] . To address this limitation, we adopt a simulation-ensemble perspective in which we treat a nominal ABM as a generator of plausible system dynamics. By systematically perturbing key model parameters, we generate a large ensemble of simulated trajectories spanning biologically plausible regimes of TME evolution. This ensemble defines a trajectory landscape whose metastable regions serve as attractors of the TME dynamics, enabling the construction of reduced-order, discrete-state representations suitable for Markov modeling and control design. We validate this landscape by mapping clinical biospecimens to their nearest attractor states and associating the resulting assignments with clinical outcomes. A parameter sensitivity analysis then identifies which biological parameters govern attractor selection and partition the landscape into distinct dynamical regimes. Building on this reduced-order representation, we introduce a Markov State Model (MSM) to learn the transition structure among system states and formulate a finite-horizon Markov Decision Process (MDP) to optimize treatment schedules. II Problem Formulation II-A Agent-Based Model of the TME We consider a discrete-time ABM of the TME, implemented in the PhysiCell framework [ 7 ] using the cell behavior grammar of Johnson et al. [ 8 ] . For simulation i with parameter vector \mathbf{p}^{i} , the configuration of all agents defines the system state at time k , \mathcal{A}_{k}^{i}=\{a_{k,1}^{i},a_{k,2}^{i},\dots,a_{k,N_{k}^{i}}^{i}\}, (1) where N_{k}^{i} is the time-varying number of agents. To define the observation map, we focus on the MTI-observable components of each agent—spatial location and cell type—and represent each agent as a_{k,j}^{i}=\big(x_{k,j}^{i},\,y_{k,j}^{i},\,c_{k,j}^{i}\big) (2) where (x_{k,j}^{i},\,y_{k,j}^{i})\in\mathbb{R}^{2} denotes the spatial location of agent j , and c_{k,j}^{i}\in\mathcal{C}=\{c_{\mathrm{tum}},c_{\mathrm{T_{0}}},c_{\mathrm{T_{eff}}},c_{\mathrm{T_{exh}}},c_{\mathrm{M0}},c_{\mathrm{M1}},c_{\mathrm{M2}}\} denotes its cell type. The ABM evolves according to a stochastic update rule governed by local behavioral interactions: \mathcal{A}_{k+1}^{i}=\mathcal{F}\!\left(\mathcal{A}_{k}^{i},\,\mathbf{p}^{i},\,\xi_{k}\right), (3) where \mathcal{F} denotes the simulator update map and \xi_{k} represents stochastic draws associated with the behavioral rules governing proliferation, apoptosis, migration, and phenotypic transitions. The interaction rules encoded in \mathcal{F} implement the signaling architecture illustrated in Fig. 1 . Because these rules act on individual agents, the resulting system state is high-dimensional and varies over time. A key open question is which of the sampled parameters in \mathbf{p}^{i} most strongly determine the long-run behavior (i.e., the terminal attractor state reached after sufficient simulation time) of the system. Fig. 1: Agent-based TME signaling architecture. The model encodes seven cell types and the signaling interactions governing their transitions; the T-cell exhaustion rate r_{\mathrm{exh}} is the primary control-relevant parameter. T-cell exhaustion ( r_{\mathrm{exh}} ) is a state transition rate governing the progressive loss of effector function in tumor-infiltrating T cells; immunotherapeutic interventions such as checkpoint blockade act in part by reducing this rate. II-B Observation Map via Spatial Statistics To enable comparison between simulations and MTI data, and to account for the variable number of cells in each configuration, we represent each agent configuration \mathcal{A}_{k}^{i} (the state of the ABM at time step k ) using a fixed-dimensional vector of spatial summary statistics and composition features. Specifically, we define an observation map that transforms each configuration of agents into a feature vector: u_{k}^{i}=\mathcal{U}\!\left(\mathcal{A}_{k}^{i}\right)\in\mathbb{R}^{M}, (4) where M denotes the number of spatial statistics extracted by \mathcal{U}(\cdot) , i=1,\ldots,N indexes simulations, and k=1,\ldots,K indexes time steps. The \ell -th component u_{k,\ell}^{i} denotes a single spatial statistic, for \ell=1,\ldots,M . These features include cell-type proportions, spatial mixing or segregation metrics, neighborhood interaction statistics, and graph-based descriptors of tissue organization. Stacking these observations across time yields a sequence U^{i}=\left[u_{1}^{i},u_{2}^{i},\dots,u_{K}^{i}\right]\in\mathbb{R}^{M\times K}. (5) which provides a fixed-dimensional representation of each simulation trajectory \mathbf{p}^{i} suitable for clustering and Markov State Model (MSM) estimation. II-C Temporal Embedding to Capture Dynamics Because u_{k}^{i} is a partial observation of the ABM state, treating each time point independently may lead to clustering that ignores temporal continuity within a trajectory. To incorporate temporal context, we adopt a delay-embedding approach inspired by Takens’ theorem [ 11 ] . Although Takens’ theorem formally applies to smooth deterministic systems, delay embedding is used here as a practical reconstruction heuristic for recovering latent dynamics from partial observations. Prior work has demonstrated the effectiveness of this approach in discrete biological systems [ 12 ] , and we empirically validate

Read the complete text